Study of immunomodulatory effects of mesenchymal stem cell-derived exosomes in a mouse model of LPS induced systemic inflammation

This publication has 59 references indexed in Scilit:

• Mesenchymal stromal (stem) cells suppress pro-inflammatory cytokine production but fail to improve survival in experimental staphylococcal toxic shock syndrome
  BMC Immunology, 2014
• Human Wharton’s jelly-derived mesenchymal stromal cells reduce renal fibrosis through induction of native and foreign hepatocyte growth factor synthesis in injured tubular epithelial cells
  Stem Cell Research & Therapy, 2013
• Human Embryonic Mesenchymal Stem Cell-Derived Conditioned Medium Rescues Kidney Function in Rats with Established Chronic Kidney Disease
  PLOS ONE, 2012
• Human chorionic-plate-derived mesenchymal stem cells and Wharton’s jelly-derived mesenchymal stem cells: a comparative analysis of their potential as placenta-derived stem cells
  Cell and tissue research, 2011
• Pro-Inflammatory Cytokines, IFNγ and TNFα, Influence Immune Properties of Human Bone Marrow and Wharton Jelly Mesenchymal Stem Cells Differentially
  PLOS ONE, 2010
• Clinical relevance of the severe abnormalities of the T cell compartment in septic shock patients
  Critical Care, 2009
• Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production
  Nature Medicine, 2008
• Increased circulating regulatory T cells (CD4+CD25+CD127−) contribute to lymphocyte anergy in septic shock patients
  Intensive Care Medicine, 2008
• Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008
  Intensive Care Medicine, 2007
• The Pathophysiology and Treatment of Sepsis
  New England Journal of Medicine, 2003